Details

Résumé de l'examen de l'innocuité - Halaven (mésylate d'éribuline) - Évaluation du risque potentiel d'effets indésirables graves au niveau de la peau | Drug and Health Products Portal

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 13, 2026 · edition #6
Timestamp: 2026-04-13T11:53:05.711Z
Language: fr
Original URL: https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR00194
Replay URL: https://replay.healtharchive.ca/job-6/20260413115305/https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR00194#ha_snapshot=386590
ID: 386590
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

View View diff Raw HTML ↗Metadata JSON ↗Cite Report issue All snapshots

Other snapshots

Apr 13, 2026 · (this snapshot)
hc-20260101
View Details
Jan 5, 2026
hc-20260101
View Details

Archived page preview